• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

122
87
73
64
40

COUNTRY

22
18
17
16
16

CATEGORIES

  • 136
  • 125
  • 89
  • 60
  • 52
  • 38
  • 30
  • 29
  • 14
  • 9
  • 8
  • 8
  • 8
  • 7
  • 7
  • 6
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

197
222
272
534

PUBLISHED

3
21
91
534

PRODUCT TYPE

340
90
85
15
3
1

Search "Antiviral Drugs - DUPLICATE" returned 534 results.

PRODUCT TITLE
Antiviral Drug Development Antiviral Drug Development - Product Thumbnail Image

Antiviral Drug Development

A major topic in the field of virology, the development of antiviral drugs continues to both generate and utilize some of the most interesting, provocative and valuable insights in related research...

May 2011
FROM

Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market

GBI Research, the leading business intelligence provider, has released its latest research “Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics...

April 2012
FROM
Competitor Analysis: Antiviral Antibodies Competitor Analysis: Antiviral Antibodies - Product Thumbnail Image

Competitor Analysis: Antiviral Antibodies

This report, as of July 2008, provides a competitor analysis in the development pipeline of novel antibodies against viral infections such as hepatitis C virus (HCV), hepatitis B virus, SARS coronavirus,...

July 2008
FROM
European Antiviral Drug and Vaccine Markets European Antiviral Drug and Vaccine Markets - Product Thumbnail Image

European Antiviral Drug and Vaccine Markets

Success in this market lies less in mergers and acquisitions than in effective collaboration between R&D functions of large multinational and small biotechnology companies. This report from Frost...

October 1997
FROM

Antiviral Drug Strategies. Methods and Principles in Medicinal Chemistry

By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics...

April 2011

Antiviral Drugs. From Basic Discovery Through Clinical Trials

This book focuses on new small molecule approaches to combat viral infections. The chapters describe the discovery and development from bench through the clinic of relatively recently-approved antiviral...

July 2011

The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)

The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they...

October 2009
FROM
Antiviral Therapeutics - Technologies, Markets and Companies Antiviral Therapeutics - Technologies, Markets and Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets and Companies

This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics The introduction starts with a practical...

July 2014
FROM

Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth

Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth Summary GBI Research in its present report ”Generics...

June 2012
FROM

Advances in Antiviral Drug Design, Vol 5

Regularly reviewing the "state-of-the-art" developments in the antiviral drug research field, this latest volume spans the conceptual design and chemical synthesis of new antiviral compounds. It discusses...

July 2007

Anti-infectious Disease Drugs Markets in China

China's demand for Anti-infectious Disease Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's...

June 2014
FROM
Advances in Antiviral Drug Design, Volume 4 Advances in Antiviral Drug Design, Volume 4 - Product Thumbnail Image

Advances in Antiviral Drug Design, Volume 4

The fourth volume of Advances in Antiviral Drug Design is keeping up with the recent progress made in the broad field of antiviral drug research and encompasses six specific directions that have opened...

December 2003
Advances in Antiviral Drug Design, Volume 3, Vol 3 Advances in Antiviral Drug Design, Volume 3, Vol 3 - Product Thumbnail Image

Advances in Antiviral Drug Design, Volume 3, Vol 3

Volume 3 of Advances in Antiviral Drug Design is keeping up with the recent progress made in the field of antiviral drug research and highlights five specific directions that have opened new avenues...

November 1999
Anti-Viral Agents, Vol 67 Anti-Viral Agents, Vol 67 - Product Thumbnail Image

Anti-Viral Agents, Vol 67

This new volume of Advances in Pharmacology explores the current state of antiviral agents. Chapters cover such topics as virus entry inhibitors, interferon-free drug combinations, and antiviral agents...

September 2013

Drug Reconstitution at the Point-of-Care: Therapeutic Markets, Technologies, Strategies, and Prospects

The inherent instability of biological drugs is a limitation that has a direct impact on the drug delivery sector Therapeutic proteins must either be stored under special conditions or formulated to...

January 2012
FROM

Drug Injection Devices to 2018. Devices, Markets, Strategies and Forecasts

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them This shift has fostered change on several...

September 2013
FROM

Advanced Therapy for Hepatitis C

Hepatologists, both researchers and front-line clinicians, now have a comprehensive guide to the treatment of patients with the HCV virus. This book focuses mainly on the efficacy and clinical use of...

December 2011
Therapeutic Drug Monitoring - Technologies, Markets, and Companies Therapeutic Drug Monitoring - Technologies, Markets, and Companies - Product Thumbnail Image

Therapeutic Drug Monitoring - Technologies, Markets, and Companies

This report deals with therapeutic drug monitoring, a multi-disciplinary clinical specialty, aimed at improving patient care by monitoring drug levels in the blood to individually adjust the dose of...

July 2014
FROM
The Antivirals Market Outlook: Market Analysis of Future Growth and Leading Players by Sector The Antivirals Market Outlook: Market Analysis of Future Growth and Leading Players by Sector - Product Thumbnail Image

The Antivirals Market Outlook: Market Analysis of Future Growth and Leading Players by Sector

'The Antivirals Market Outlook: Market Analysis of Future Growth and Leading Players by Sector' provides an analysis of changing market conditions and strategic future outlook, an unrivalled source...

January 2005
FROM
Pharmasset’s R7128 - Will monkey findings cause havoc for this novel anti-HCV polymerase inhibitor? Pharmasset’s R7128 - Will monkey findings cause havoc for this novel anti-HCV polymerase inhibitor? - Product Thumbnail Image

Pharmasset’s R7128 - Will monkey findings cause havoc for this novel anti-HCV polymerase inhibitor?

R7128 is a promising nucleoside polymerase inhibitor for the treatment of hepatitis C A review of the clinical data available so far, with a discussion of the kidney toxicities observed in a monkey...

May 2009
FROM
Loading Indicator